TIFFANY MURRELL: Open Payments
NPI 1871090100 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 52 payments from 17 companies in 2025. Trend: 2023 $728 · 2024 $889 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $291 |
| Eisai Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| ANI Pharmaceuticals, Inc. | 3 | $49 |
| Alexion Pharmaceuticals, Inc. | 2 | $47 |
| Amgen Inc. | 2 | $33 |
| Globus Medical, Inc. | 1 | $32 |
| ARGENX US, INC. | 1 | $29 |
| EMD Serono, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: QULIPTA, UBRELVY, Leqembi, HYQVIA, PURIFIED CORTROPHIN GEL, ULTOMIRIS, VYALEV, BOTOX.
Industry payments across IN — which companies pay providers there.
